Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
about
Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsHow I treat acquired aplastic anemiaAlternative donor transplant of benign primary hematologic disordersUnrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.Chronic graft-versus-host disease (GVHD) in children.First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapyNew advances in hematopoietic cell transplantationCurrent outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysisFavorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia.Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the fieldSuccess of allogeneic marrow transplantation for children with severe aplastic anaemia.Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.Myelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention.Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.How I manage aplastic anaemia in children.Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.Current management of severe acquired aplastic anemia.High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.Matched sibling donors versus alternative donors in allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia in México.Costs and consequences of immunosuppressive therapy in children with aplastic anemia.Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients.Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.Outcome of pediatric acquired aplastic anemia: a developing world experience.Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning.Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia.Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia.Unrelated donor cord blood transplantation for non-malignant disorders in children and adolescents.Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia
P2860
Q24187102-5EBA2CE8-B60B-4A63-9104-9ABE106629E9Q24187108-F91F5075-BE27-452D-BFC1-825AA6C0AB0FQ24200272-9FE77CA6-A892-402D-9502-9B69BE6E7491Q24200282-E8E514BB-EDA0-427A-94C8-C4057EC0F389Q24200648-C30183D3-1D08-451B-9F77-AE34A95AE923Q24202963-E92D3B6C-5AC8-49EF-A56E-D9AFD2BFF05BQ24617687-15F49E31-BDDD-4A83-BC6D-FC7ADE81C1CEQ26823398-58788DB7-A297-4744-8EF5-1F56D1D0ED15Q33489272-03CC1320-E94E-45CC-A6E2-3C8207F90AD7Q33857680-E287A299-4457-48CC-A51A-CCE3DC1A58EDQ34649082-454F05BB-A924-4C43-B98C-D2B690F663F9Q35213018-70888BFB-7B27-4C39-9FF2-6B3D865A0DF2Q35571068-A596C689-2D23-4C74-A0FF-D42984AC6E83Q36514033-B82E3D17-2B05-4B8C-A574-9D287852B402Q36909167-23D97420-CB7B-4F86-BA8A-76E7F5E138B3Q36958013-905F83AE-9499-4C39-85D4-1C32B1A522D2Q36961081-B1DF4597-8CB8-4540-AC7E-66C866A1E3C1Q37229440-0DE44AC5-63D4-4201-9D9A-6B6ED0486E04Q37677193-E1AD0810-B780-4279-9DB7-B06CA5B1423FQ37770210-5DAFF6C6-8862-4C29-8114-790385B39BFAQ37986162-43B53B3D-B5CE-4BEA-867D-0FFDB8C85B33Q38062303-7B12080A-A6DD-44AA-8D21-CBABB497827FQ38103184-14B4C1F6-7200-4F30-94FC-A73E75880D82Q38261555-09B8D275-3C2F-416A-8EED-D7B32C51528FQ38694686-5B3BEBE8-9603-4830-8110-A3B384B411DCQ40496183-EAA8805B-9BBE-4CB8-AE8D-77B4D7222193Q41584606-8E21FF2C-FFA6-40A7-845B-09E1139857FCQ42743020-EF13464F-DB90-46C8-A130-ECD9B570B0F5Q43143185-F0653F99-C505-4863-993F-36A79E4D7D6DQ43445845-E67E4441-C5FB-46D5-A7DF-E71E89B51359Q44385094-D97B16B3-3AF3-407E-BE20-3E4E5029FDD8Q46768308-6F5A30E6-0C76-43C4-98B1-18F6139D77C9Q47126486-95C8A815-9A84-4166-AC0E-34BA5C83C6B1Q47865904-CC6F0F32-23AD-4CD3-A5D0-65367EDDC967Q50595454-E8D9B239-9752-4C57-8DE6-CBE365723479Q53460735-F2CC933E-B139-4DFA-BD2E-ABD07E27028CQ54392397-7AC8D8F5-1B63-4777-ACB7-229529D7422DQ58449850-5E8614C9-4150-4E15-B872-4BA4F8D502F8
P2860
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Comparable outcomes of matched ...... iatric severe aplastic anemia.
@en
Comparable outcomes of matched ...... iatric severe aplastic anemia.
@nl
type
label
Comparable outcomes of matched ...... iatric severe aplastic anemia.
@en
Comparable outcomes of matched ...... iatric severe aplastic anemia.
@nl
prefLabel
Comparable outcomes of matched ...... iatric severe aplastic anemia.
@en
Comparable outcomes of matched ...... iatric severe aplastic anemia.
@nl
P2093
P1476
Comparable outcomes of matched ...... iatric severe aplastic anemia.
@en
P2093
Alana A Kennedy-Nasser
Anita Mahajan
Catherine M Bollard
George Carrum
Heidi L Weiss
Helen E Heslop
James A Arce
Kathryn S Leung
Malcolm K Brenner
Robert A Krance
P304
P356
10.1016/J.BBMT.2006.07.011
P577
2006-12-01T00:00:00Z